Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Research Article

Characterization of rifampin-resistance in pathogenic mycobacteria.

D L Williams, C Waguespack, K Eisenach, J T Crawford, F Portaels, M Salfinger, C M Nolan, C Abe, V Sticht-Groh, T P Gillis
D L Williams
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Waguespack
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Eisenach
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J T Crawford
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Portaels
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Salfinger
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C M Nolan
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Abe
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V Sticht-Groh
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T P Gillis
GWL Hansen's Disease Research Laboratory, Baton Rouge, LA 70894.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.38.10.2380
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The emergence of rifampin-resistant strains of pathogenic mycobacteria has threatened the usefulness of this drug in treating mycobacterial diseases. Critical to the treatment of individuals infected with resistant strains is the rapid identification of these strains directly from clinical specimens. It has been shown that resistance to rifampin in Mycobacterium tuberculosis and Mycobacterium leprae apparently involves mutations in the rpoB gene encoding the beta-subunit of the RNA polymerases of these species. DNA sequences were obtained from a 305-bp fragment of the rpoB gene from 110 rifampin-resistant and 10 rifampin-susceptible strains of M. tuberculosis from diverse geographical regions throughout the world. In 102 of 110 rifampin-resistant strains 16 mutations affecting 13 amino acids were observed. No mutations were observed in rifampin-susceptible strains. No association was found between particular mutations in the rpoB gene and drug susceptibility patterns of multidrug-resistant M. tuberculosis strains. Drug-resistant M. tuberculosis strains from the same outbreak and exhibiting the same IS6110 DNA fingerprint and drug susceptibility pattern contained the same mutation in the rpoB gene. However, mutations are not correlated with IS6110 profiling outside of epidemics. The evolution of rifampin resistance as a consequence of mutations in the rpoB gene was documented in a patient who developed rifampin resistance during the course of treatment. Rifampin-resistant strains of M. leprae, Mycobacterium avium, and Mycobacterium africanum contained mutations in the rpoB gene similar to that documented for M. tuberculosis. This information served as the basis for developing a rapid DNA diagnostic assay (PCR-heteroduplex formation) for the detection of rifampin susceptibility of M. tuberculosis.

PreviousNext
Back to top
Download PDF
Citation Tools
Characterization of rifampin-resistance in pathogenic mycobacteria.
D L Williams, C Waguespack, K Eisenach, J T Crawford, F Portaels, M Salfinger, C M Nolan, C Abe, V Sticht-Groh, T P Gillis
Antimicrobial Agents and Chemotherapy Oct 1994, 38 (10) 2380-2386; DOI: 10.1128/AAC.38.10.2380

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of rifampin-resistance in pathogenic mycobacteria.
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characterization of rifampin-resistance in pathogenic mycobacteria.
D L Williams, C Waguespack, K Eisenach, J T Crawford, F Portaels, M Salfinger, C M Nolan, C Abe, V Sticht-Groh, T P Gillis
Antimicrobial Agents and Chemotherapy Oct 1994, 38 (10) 2380-2386; DOI: 10.1128/AAC.38.10.2380
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596